Dr. McCullough sheds light on China’s long-term interest in cornering the drug supply market

Dr. Peter McCullough, Chief Scientific Officer at The Wellness Company, explains the motivation and strategy behind China’s monopoly on the pharmaceutical supply chain. “So now we’re stuck because if we ever really got into a tough situation with China, in a sense they could put the squeeze and shut off our drug supply,” Dr. McCullough says.